Om Megashree Pharmaceuticals Issuing IPO Shares to Foreign Nepalese Immigrants from Magh 21

Om Megashree Pharmaceuticals Limited has published an offer letter to issue an Initial Public Offering (IPO) to Foreign Nepalese Immigrants.

The IPO issue for the Foreign Nepalese Immigrants will open from the 21st Magh to the 5th Falgun, 2081. Note that the issue will not be extended from the early closing date for Nepalese citizens working abroad.

The issued capital of the company is Rs. 60 Crores of which 30% i.e. 18,00,000 unit shares worth Rs. 18 Crores will be issued later for the general public. Of this public issue, 10% of the shares totaling 1,80,000 units shares have been allocated for Nepalese citizens working abroad, the issue of which will open on the date mentioned above.

Out of the total 18,00,000 units, 90,000 (i.e. 5% of 18,00,000) have been set aside for mutual funds and 54,000 (i.e. 3% of 18,00,000) units have been set aside for the employees of the company. The remaining 14,76,000 units are for the general public.

Prabhu Capital has been appointed as the issue manager for the IPO issuance. Applications could be placed for a minimum of 10 units and a maximum of 10,000 units.

CARE Ratings Nepal Limited (CRNL) has reaffirmed the ‘CARE-NP BB- (Is)’ rating for Om Megashree Pharmaceuticals Limited (OMPL), indicating moderate default risk for timely financial obligations. Additionally, CRNL has reaffirmed the ‘CARE-NP BB-’ rating for OMPL’s long-term bank facilities and the ‘CARE-NP A4’ rating for its short-term bank facilities.

Om Megashree Pharmaceuticals Limited, established on June 12, 2016, is a public limited company in Nepal, promoted by a group of institutional and individual investors. The company manufactures pharmaceutical products at its Chitwan-based plant and began partial operations on February 19, 2024.

Offer Letter: